The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...
The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...
For those who have tried unsuccessfully to use a CPAP machine to treat sleep apnea, the Inspire implant is a breakthrough ...
The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep ...
More than 60 million Americans battle insomnia, and counting sheep, reading dull books or skipping naps isn't helping. Here ...
A new evidence review says that coffee and tea consumption are linked to a lower risk of cancers of the mouth, throat, and head and neck, per the results published in the journal Cancer.
The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...
The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to ...
The U.S. Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the ...
FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity.
The nod, just months after topline results from SURMOUNT-OSA came out, makes it the first drug approved for this indication.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback